Understanding this concept is essential for both healthcare professionals and patients, as it directly influences dosing frequency, time to steady state, and the duration of therapeutic effect
Compared to monotherapies that often lead to dose escalation and tolerance, these co-delivery platforms demonstrate prolonged efficacy at lower doses, reducing adverse effects and improving patient outcomes
(Medicare does cover GLP-1 drugs when theyre prescribed for Type 2 diabetes, cardiovascular disease and other health problems.) In order to get it permanent, it literally takes an act of Congress
Mori M, Dhruva S, Geirsson A, Krumholz H
Most see significant weight loss within 37 months
2024;40(9):2477-2490.e1